Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$41.5M Buy
104,499
+942
+0.9% +$268K 0.06% 277
2026
Q1
$18M Buy
103,557
+2,765
+3% +$567K 0.03% 414
2025
Q4
$25.8M Buy
100,792
+3,361
+3% +$881K 0.04% 341
2025
Q3
$25.3M Buy
97,431
+7,678
+9% +$2.02M 0.05% 330
2025
Q2
$21.9M Buy
89,753
+5,657
+7% +$1.41M 0.05% 347
2025
Q1
$22.3M Buy
84,096
+11,458
+16% +$3.1M 0.05% 325
2024
Q4
$18.4M Sell
72,638
-8,670
-11% -$2.33M 0.05% 337
2024
Q3
$25.8M Buy
81,308
+1,801
+2% +$641K 0.07% 306
2024
Q2
$29.7M Buy
79,507
+10,845
+16% +$3.66M 0.08% 271
2024
Q1
$23.8M Buy
68,662
+10,740
+19% +$4.07M 0.08% 296
2023
Q4
$26.5M Buy
57,922
+4,239
+8% +$2.09M 0.1% 261
2023
Q3
$26.1M Buy
53,683
+13,799
+35% +$6.48M 0.11% 231
2023
Q2
$17.8M Sell
39,884
-2,334
-6% -$1.17M 0.07% 338
2023
Q1
$20.5M Sell
42,218
-1,711
-4% -$846K 0.09% 328
2022
Q4
$22.5M Sell
43,929
-2,135
-5% -$1.12M 0.11% 264
2022
Q3
$22.4M Sell
46,064
-3,222
-7% -$1.57M 0.13% 206
2022
Q2
$23.1M Buy
49,286
+13,842
+39% +$6.16M 0.12% 215
2022
Q1
$15.4M Sell
35,444
-72,172
-67% -$30.2M 0.08% 316
2021
Q4
$49.9M Sell
107,616
-7,234
-6% -$3.2M 0.21% 99
2021
Q3
$44.7M Sell
114,850
-9,525
-8% -$4.04M 0.2% 108
2021
Q2
$55.1M Buy
124,375
+24,066
+24% +$10.5M 0.24% 89
2021
Q1
$42.1M Sell
100,309
-2,143
-2% -$855K 0.21% 108
2020
Q4
$42M Buy
102,452
+59,783
+140% +$24.9M 0.22% 98
2020
Q3
$17.7M Sell
42,669
-34,984
-45% -$14.1M 0.1% 175
2020
Q2
$30.1M Buy
77,653
+31,135
+67% +$11.6M 0.19% 105
2020
Q1
$14.6M Sell
46,518
-627
-1% -$211K 0.11% 166
2019
Q4
$17.3M Sell
47,145
-468
-1% -$148K 0.1% 173
2019
Q3
$12.2M Sell
47,613
-2,403
-5% -$674K 0.08% 222
2019
Q2
$13.3M Sell
50,016
-1,271
-2% -$322K 0.09% 213
2019
Q1
$13.6M Sell
51,287
-661
-1% -$190K 0.09% 218
2018
Q4
$14.9M Sell
51,948
-14,639
-22% -$4.64M 0.11% 190
2018
Q3
$22.5M Sell
66,587
-2,401
-3% -$780K 0.12% 176
2018
Q2
$20.5M Sell
68,988
-928
-1% -$272K 0.12% 183
2018
Q1
$18.8M Sell
69,916
-9,618
-12% -$2.6M 0.11% 195
2017
Q4
$19.7M Sell
79,534
-12,978
-14% -$3.2M 0.11% 209
2017
Q3
$22.5M Buy
92,512
+749
+0.8% +$184K 0.12% 197
2017
Q2
$22.1M Sell
91,763
-180
-0.2% -$40.8K 0.12% 193
2017
Q1
$19M Sell
91,943
-15,856
-15% -$3.28M 0.11% 211
2016
Q4
$22M Buy
107,799
+5,715
+6% +$1.09M 0.13% 173
2016
Q3
$18.1M Buy
102,084
+2,300
+2% +$399K 0.11% 215
2016
Q2
$18M Buy
99,784
+13,204
+15% +$2.35M 0.12% 192
2016
Q1
$15.8M Buy
86,580
+1,632
+2% +$283K 0.12% 188
2015
Q4
$15.2M Sell
84,948
-1,148
-1% -$201K 0.12% 194
2015
Q3
$15.4M Sell
86,096
-19,526
-18% -$3.61M 0.13% 181
2015
Q2
$20.2M Buy
105,622
+7,584
+8% +$1.41M 0.14% 170
2015
Q1
$17.5M Buy
98,038
+6,867
+8% +$1.09M 0.12% 191
2014
Q4
$13.1M Buy
91,171
+1,095
+1% +$150K 0.1% 234
2014
Q3
$11.7M Sell
90,076
-148
-0.2% -$18.8K 0.09% 244
2014
Q2
$11.5M Sell
90,224
-577
-0.6% -$68.3K 0.09% 258
2014
Q1
$10.2M Sell
90,801
-5,171
-5% -$539K 0.08% 263
2013
Q4
$9.91M Sell
95,972
-79,609
-45% -$7.8M 0.08% 270
2013
Q3
$16.4M Buy
175,581
+4,098
+2% +$376K 0.14% 180
2013
Q2
$14.5M Buy
+171,483
New +$13.5M 0.15% 177

Other funds holding HUM

Aviva's HUM Position: Q2 2026 in Review

Aviva increased its Humana (HUM) stake by 0.91% in Q2 2026, buying an estimated $268K and bringing the position to 104,499 shares worth $41.5M. The position accounts for 0.06% of the portfolio, ranked #277.

Aviva first reported a position in HUM in Q2 2013 and has held it in 53 quarters since. The position peaked at $55.1M in Q2 2021. 923 funds tracked by Wall St. Rank hold HUM as of Q2 2026.

  • Aviva held 104,499 shares of Humana worth $41.5M as of Q2 2026.
  • Aviva bought 942 Humana shares in Q2 2026, an estimated $268K.
  • Humana made up 0.06% of Aviva's portfolio in Q2 2026, its #277 holding.
  • Aviva first reported a position in Humana in Q2 2013 and has held it in 53 quarters since.
  • Aviva's Humana position peaked at $55.1M in Q2 2021.
  • 923 funds tracked by Wall St. Rank held Humana as of Q2 2026.

Based on Aviva's 13F filing for Q2 2026, filed 13 Aug 2026.